about
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors α/γ dual agonistsNew 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expressionOccurrence of patulin in conventional and organic fruit products in Italy and subsequent exposure assessment.Reduction of Aflatoxins in Apricot Kernels by Electronic and Manual Color SortingOpen tubular columns containing the immobilized ligand binding domain of peroxisome proliferator-activated receptors α and γ for dual agonists characterization by frontal affinity chromatography with mass spectrometry detection.Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor α/γ ligand LT175.Plant Food Supplements with Antioxidant Properties for the Treatment of Chronic and Neurodegenerative Diseases: Benefits or Risks?Deep Eutectic Solvents as Novel and Effective Extraction Media for Quantitative Determination of Ochratoxin A in Wheat and Derived Products.Hydroxypyridinone derivatives: a fascinating class of chelators with therapeutic applications - an update.Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARalpha and PPARgamma agonist activity.Synthesis, biological evaluation, and molecular modeling investigation of chiral phenoxyacetic acid analogues with PPARalpha and PPARgamma agonist activity.Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy.New approaches for prevention and treatment of Alzheimer's disease: a fascinating challenge.Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.Effect of gaseous ozone treatments on DON, microbial contaminants and technological parameters of wheat and semolina.New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity.Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors α/γ agonists.Food coloring agents and plant food supplements derived from Vitis vinifera: a new source of human exposure to ochratoxin A.Natural Scaffolds with Multi-Target Activity for the Potential Treatment of Alzheimer's DiseaseIdentification of the First PPARα/γ Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARγ and To Inhibit Its Cdk5-Mediated PhosphorylationAn innovative approach for the treatment of Alzheimer's disease: the role of peroxisome proliferator-activated receptors and their ligands in development of alternative therapeutic interventionsChiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonistsDeep Eutectic Solvents as Effective Reaction Media for the Synthesis of 2-Hydroxyphenylbenzimidazole-based Scaffolds en Route to Donepezil-Like CompoundsDesign, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's DiseaseCombining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer's diseaseA Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic DisordersDonepezil structure-based hybrids as potential multifunctional anti-Alzheimer's drug candidatesEffects of temperature and water activity change on ecophysiology of ochratoxigenic Aspergillus carbonarius in field-simulating conditionsNovel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's DiseaseAn update about the crucial role of stereochemistry on the effects of Peroxisome Proliferator-Activated Receptor ligandsVirtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitorsNew Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) ActivationBone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy
P50
Q27677316-28FC97BB-9D38-47AC-B8F3-D4BCB74EA817Q27683494-B34D4A02-65A0-46C0-B921-290C729CB80AQ34434062-D19F4043-E15E-450D-8473-B5D18E1FCE83Q36507224-11876574-23F7-4DBE-90C9-994B08794926Q36744783-0E7258CE-C850-4F49-94E2-2632FBB36E32Q38929844-E4DAE960-6D1B-4B8E-86CA-9B72F76A8685Q39022100-7A5D88D4-8FA2-41DA-90AE-2395929E5368Q39022332-A89F98F7-643D-454B-AE81-E6EDC6FF014AQ39209055-50695925-092F-4709-BC82-82248B8D4AD0Q39932505-D9AAA117-B637-4776-83A8-EAAA370A5B84Q40159652-4304C7D7-1F70-4722-B9A3-96BF91080F5BQ41667368-CC7AEF98-23B6-497C-8D73-8D73B0EFD28CQ41772113-F0835E42-FECE-4C25-B542-B9829F336B82Q46497632-70CC191B-D8F3-4617-A87F-E82373387AFDQ49570393-2462BEFE-2813-4845-B8C9-299CCBA65D0FQ51199503-AB3A7408-9660-4DB8-BB58-9776B9E24E6EQ51243956-E8F370F1-EF5A-4914-8170-DEEC10390D19Q53222445-A751EE21-8FE1-4706-95AC-C154BACA9424Q57166995-E290C002-3389-4C1E-BC7E-1B7A05B5DEB1Q58106333-DC3D1F7A-811C-4DAA-898A-4BB022AB1B7DQ60923246-B2F990D0-1E44-4167-98B2-6D6845F9AB2DQ64097677-02744EF7-FA60-4FD8-BE00-CF098C1FD064Q89510771-F5B42B2A-D7D5-48FE-B846-DFE84D53A844Q89880116-DC3FA136-86C0-4189-857A-02F65059E98AQ90175429-85092D6A-A848-47CF-BD2C-260733F53981Q90295936-7F1B81FA-B919-40FF-AE88-2410AF73C563Q91218741-BFD97E35-7A4F-456F-A038-65B1B8DC1475Q91297858-4F25B000-0D3D-4C30-8C60-316DCAF4B52DQ91418587-D05D641B-63CB-4CE9-B95A-0186D3A56C54Q92190771-99D837A3-80CB-402B-BF42-08A4A51933A7Q92237853-622E7959-9DBD-414E-ADCD-2E2F21085421Q92589154-7B3C2054-5211-47B4-9309-6E82B3DB0A14Q96125401-7C956FB4-463C-4C13-B38D-FB89363D4F56
P50
description
investigador
@es
researcher
@en
name
Luca Piemontese
@en
Luca Piemontese
@nl
type
label
Luca Piemontese
@en
Luca Piemontese
@nl
prefLabel
Luca Piemontese
@en
Luca Piemontese
@nl
P31
P496
0000-0002-7980-5818